Monitoring of First-line Drug Resistance Mutations Outside the Scope of Xpert MTB/RIF Ultra is Needed for Successful Control of DR-TB in Southern Mozambique
Clinical infectious diseases/Clinical infectious diseases (Online. University of Chicago. Press)